BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 15604276)

  • 41. Peptides and peptidomimetics in the p53/MDM2/MDM4 circuitry - a patent review.
    Teveroni E; Lucà R; Pellegrino M; Ciolli G; Pontecorvi A; Moretti F
    Expert Opin Ther Pat; 2016 Dec; 26(12):1417-1429. PubMed ID: 27603098
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Molecular pathways: targeting Mdm2 and Mdm4 in cancer therapy.
    Li Q; Lozano G
    Clin Cancer Res; 2013 Jan; 19(1):34-41. PubMed ID: 23262034
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The regulation of the p53-mediated stress response by MDM2 and MDM4.
    Perry ME
    Cold Spring Harb Perspect Biol; 2010 Jan; 2(1):a000968. PubMed ID: 20182601
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Regulation of kidney development by the Mdm2/Mdm4-p53 axis.
    El-Dahr S; Hilliard S; Saifudeen Z
    J Mol Cell Biol; 2017 Feb; 9(1):26-33. PubMed ID: 28096292
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The long and the short of it: the MDM4 tail so far.
    Haupt S; Mejía-Hernández JO; Vijayakumaran R; Keam SP; Haupt Y
    J Mol Cell Biol; 2019 Mar; 11(3):231-244. PubMed ID: 30689920
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mitochondrial MDM4 (MDMX): an unpredicted role in the p53-mediated intrinsic apoptotic pathway.
    Mancini F; Moretti F
    Cell Cycle; 2009 Dec; 8(23):3854-9. PubMed ID: 19887911
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Recent Progress and Clinical Development of Inhibitors that Block MDM4/p53 Protein-Protein Interactions.
    Zhang S; Lou J; Li Y; Zhou F; Yan Z; Lyu X; Zhao Y
    J Med Chem; 2021 Aug; 64(15):10621-10640. PubMed ID: 34286973
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Small-molecule inhibitors of the p53 suppressor HDM2: have protein-protein interactions come of age as drug targets?
    Fischer PM; Lane DP
    Trends Pharmacol Sci; 2004 Jul; 25(7):343-6. PubMed ID: 15219971
    [No Abstract]   [Full Text] [Related]  

  • 49. Targeting p53 for the treatment of cancer.
    Duffy MJ; Synnott NC; O'Grady S; Crown J
    Semin Cancer Biol; 2022 Feb; 79():58-67. PubMed ID: 32741700
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Disrupting TP53 in mouse models of human cancers.
    Parant JM; Lozano G
    Hum Mutat; 2003 Mar; 21(3):321-6. PubMed ID: 12619119
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Restoring the tumour suppressive function of p53 as a parallel strategy in melanoma therapy.
    Lu M; Miller P; Lu X
    FEBS Lett; 2014 Aug; 588(16):2616-21. PubMed ID: 24844434
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Anatomy of Mdm2 and Mdm4 in evolution.
    Tan BX; Liew HP; Chua JS; Ghadessy FJ; Tan YS; Lane DP; Coffill CR
    J Mol Cell Biol; 2017 Feb; 9(1):3-15. PubMed ID: 28077607
    [TBL] [Abstract][Full Text] [Related]  

  • 53. HAUSP/USP7 as an Epstein-Barr virus target.
    Holowaty MN; Frappier L
    Biochem Soc Trans; 2004 Nov; 32(Pt 5):731-2. PubMed ID: 15494000
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Apoptotic genes in cancer therapy.
    Opalka B; Dickopp A; Kirch HC
    Cells Tissues Organs; 2002; 172(2):126-32. PubMed ID: 12426489
    [TBL] [Abstract][Full Text] [Related]  

  • 55. microRNAs and Alu elements in the p53-Mdm2-Mdm4 regulatory network.
    Hoffman Y; Pilpel Y; Oren M
    J Mol Cell Biol; 2014 Jun; 6(3):192-7. PubMed ID: 24868102
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Activation of p53 by oncogenes.
    Lowe SW
    Endocr Relat Cancer; 1999 Mar; 6(1):45-8. PubMed ID: 10732786
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Targeting MDM4 as a Novel Therapeutic Approach for Hematologic Malignancies.
    Cao L; Fan L; Xu W; Li JY
    Curr Cancer Drug Targets; 2015; 15(9):769-80. PubMed ID: 26567881
    [TBL] [Abstract][Full Text] [Related]  

  • 58. p53: an internal investigation.
    Hayon IL; Haupt Y
    Cell Cycle; 2002; 1(2):111-6. PubMed ID: 12429917
    [No Abstract]   [Full Text] [Related]  

  • 59. The role of MDM2 and MDM4 in breast cancer development and prevention.
    Haupt S; Vijayakumaran R; Miranda PJ; Burgess A; Lim E; Haupt Y
    J Mol Cell Biol; 2017 Feb; 9(1):53-61. PubMed ID: 28096293
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The Double Role of p53 in Cancer and Autoimmunity and Its Potential as Therapeutic Target.
    Fierabracci A; Pellegrino M
    Int J Mol Sci; 2016 Nov; 17(12):. PubMed ID: 27897991
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.